Combined use of 25-hydroxy-vitamin D3 and vitamin D3 for improving bone mineral density and for treating osteoporosis

Details for Australian Patent Application No. 2009214052 (hide)

Owner DSM IP Assets B.V.

Inventors Wolfram, Swen; Leuenberger, Bruno H.; Stoecklin, Elisabeth; Claerhout, Wouter; Urban, Kai; Buck, Neil Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009214052

PCT Pub. Number WO2009/101135

Priority 61/031,671 26.02.08 US; 61/028,510 13.02.08 US; 61/036,928 15.03.08 US; 61/036,922 14.03.08 US

Filing date 12 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 31/593 (2006.01)

A23L 1/303 (2006.01) Foods or foodstuffs

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/101135 Priority application(s): WO2009/101135

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009214053-Treating hyperglycemia with 25-hydroxyvitamin D3

2009214049-Combination of vitamin D and 25-hydroxyvitamin D 3